efficacy of steroid in trans-catheter arterial chemoembolization

efficacy of steroid in trans-catheter arterial chemoembolization - efficacy of steroid in TACE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003430

Enrollment

Registered

2010-04-01

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

short term steroid administration contorl group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with hepatocellular carcinoma who underwent TACE

Exclusion criteria

Exclusion criteria: tumor thrombi in portal vein, child C stage, noncontrollable ascites, noncontrollable diabetes mellitus, extrahepatic metastasis, active gastrointestinal bleeding, use of glucocorticoids in the past 3 months

Design outcomes

Primary

Measure	Time frame
clinical symptom after TACE(abdominal pain,pyrexia,nause,vomit)	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026